CA50588/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1990	1
1992	1
1993	4
1994	2
1995	7
1996	4
1997	3
1998	5
1999	3
2000	6
2001	1
2002	1
2010	2
2011	1
2024	0

1

Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potential.

Thompson TC. Thompson TC. Yonsei Med J. 2010 Jul;51(4):479-83. doi: 10.3349/ymj.2010.51.4.479. Yonsei Med J. 2010. PMID: 20499410 Free PMC article. Review.

2

Transforming growth factor beta 1 as a biomarker for prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. J Cell Biochem Suppl. 1992;16H:54-61. doi: 10.1002/jcb.240501212. J Cell Biochem Suppl. 1992. PMID: 1289674 Review.

3

Metastasis-related genes in prostate cancer: the role of caveolin-1.

Thompson TC. Thompson TC. Cancer Metastasis Rev. 1998-1999;17(4):439-42. doi: 10.1023/a:1006110326366. Cancer Metastasis Rev. 1998. PMID: 10453288 Review.

4

Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease.

Thompson TC, Timme TL, Park SH, Yang G, Ren C. Thompson TC, et al. Prostate. 2000 Jun 1;43(4):248-54. doi: 10.1002/1097-0045(20000601)43:4<248::aid-pros3>3.0.co;2-p. Prostate. 2000. PMID: 10861743 Review.

5

In situ gene therapy for prostate cancer: immunomodulatory approaches.

Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.

6

Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.

Timme TL, Truong LD, Slawin KM, Kadmon D, Park SH, Thompson TC. Timme TL, et al. Microsc Res Tech. 1995 Mar 1;30(4):333-41. doi: 10.1002/jemt.1070300408. Microsc Res Tech. 1995. PMID: 7541677 Review.

7

Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.

Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC. Truong LD, et al. Hum Pathol. 1993 Jan;24(1):4-9. doi: 10.1016/0046-8177(93)90055-l. Hum Pathol. 1993. PMID: 7678092

8

Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.

Tabata K, Kurosaka S, Watanabe M, Edamura K, Satoh T, Yang G, Abdelfattah E, Wang J, Goltsov A, Floryk D, Thompson TC. Tabata K, et al. Gene Ther. 2011 Oct;18(10):969-78. doi: 10.1038/gt.2011.51. Epub 2011 Apr 21. Gene Ther. 2011. PMID: 21512508 Free PMC article.

9

Transgenic models for the study of prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. Cancer. 1993 Feb 1;71(3 Suppl):1165-71. doi: 10.1002/1097-0142(19930201)71:3+<1165::aid-cncr2820711440>3.0.co;2-u. Cancer. 1993. PMID: 8428340 Review.

10

DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.

Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme TL, Yang G, Scardino PT, Thompson TC. Greene DR, et al. Int J Cancer. 1995 Jan 27;60(3):395-9. doi: 10.1002/ijc.2910600321. Int J Cancer. 1995. PMID: 7829250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year